Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Impact of an acute hemodynamic response-guided protocol for primary prophylaxis of variceal bleeding.

Fortea JI, Puente Á, Ruiz P, Ezcurra I, Vaquero J, Cuadrado A, Arias-Loste MT, Cabezas J, Llerena S, Iruzubieta P, Rodríguez-Lope C, Huelin P, Casafont F, Fábrega E, Crespo J.

World J Clin Cases. 2018 Nov 6;6(13):611-623. doi: 10.12998/wjcc.v6.i13.611.

2.

Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey.

Fortea JI, Puente Á, Ezcurra I, Cuadrado A, Arias-Loste MT, Cabezas J, Llerena S, Iruzubieta P, Rodríguez-Lope C, Huelin P, Casafont F, Fábrega E, Crespo J.

Dig Liver Dis. 2019 Jan;51(1):95-103. doi: 10.1016/j.dld.2018.06.003. Epub 2018 Jun 12.

PMID:
29960901
3.

Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.

Forner A, Vilana R, Bianchi L, Rodríguez-Lope C, Reig M, García-Criado MÁ, Rimola J, Solé M, Ayuso C, Bru C, Bruix J.

J Hepatol. 2015 Jan;62(1):150-5. doi: 10.1016/j.jhep.2014.08.028. Epub 2014 Aug 27.

PMID:
25173969
4.

Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib.

Reig M, Torres F, Rodriguez-Lope C, Forner A, LLarch N, Rimola J, Darnell A, Ríos J, Ayuso C, Bruix J.

J Hepatol. 2014 Aug;61(2):318-24. doi: 10.1016/j.jhep.2014.03.030. Epub 2014 Apr 2.

PMID:
24703956
5.

Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma.

Finn RS, Poon RT, Yau T, Klümpen HJ, Chen LT, Kang YK, Kim TY, Gomez-Martin C, Rodriguez-Lope C, Kunz T, Paquet T, Brandt U, Sellami D, Bruix J.

J Hepatol. 2013 Dec;59(6):1271-7. doi: 10.1016/j.jhep.2013.07.029. Epub 2013 Aug 6.

PMID:
23928403
6.

Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design.

Reig M, Rimola J, Torres F, Darnell A, Rodriguez-Lope C, Forner A, Llarch N, Ríos J, Ayuso C, Bruix J.

Hepatology. 2013 Dec;58(6):2023-31. doi: 10.1002/hep.26586. Epub 2013 Oct 29.

PMID:
23787822
7.

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis.

Santoro A, Simonelli M, Rodriguez-Lope C, Zucali P, Camacho LH, Granito A, Senzer N, Rimassa L, Abbadessa G, Schwartz B, Lamar M, Savage RE, Bruix J.

Br J Cancer. 2013 Jan 15;108(1):21-4. doi: 10.1038/bjc.2012.556. Epub 2013 Jan 3.

8.

Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI.

Rimola J, Forner A, Tremosini S, Reig M, Vilana R, Bianchi L, Rodríguez-Lope C, Solé M, Ayuso C, Bruix J.

J Hepatol. 2012 Jun;56(6):1317-23. doi: 10.1016/j.jhep.2012.01.004. Epub 2012 Feb 4.

PMID:
22314420
9.

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.

Tremosini S, Forner A, Boix L, Vilana R, Bianchi L, Reig M, Rimola J, Rodríguez-Lope C, Ayuso C, Solé M, Bruix J.

Gut. 2012 Oct;61(10):1481-7. doi: 10.1136/gutjnl-2011-301862. Epub 2012 Jan 27.

PMID:
22287594

Supplemental Content

Loading ...
Support Center